The Clinical Epidemiology of Male Osteoporosis: a Review of the Recent Literature

Overview

Journal Clin Epidemiol

Publisher Dove Medical Press

Specialty Public Health

Date 2015 Feb 7

PMID 25657593

Citations 77

Authors

Tina Willson

Scott D Nelson

Jonathan Newbold

Richard E Nelson

Joanne LaFleur

Affiliations

Soon will be listed here.

Abstract

Osteoporosis, a musculoskeletal disease characterized by decreased bone mineral density (BMD) and an increased risk of fragility fractures, is now recognized as an important public health problem in men. Osteoporotic fractures, particularly of the hip, result in significant morbidity and mortality in men and lead to considerable societal costs. Many national and international organizations now address screening and treatment for men in their osteoporosis clinical guidelines. However, male osteoporosis remains largely underdiagnosed and undertreated. The objective of this paper is to provide an overview of recent findings in male osteoporosis, including pathophysiology, epidemiology, and incidence and burden of fracture, and discuss current knowledge about the evaluation and treatment of osteoporosis in males. In particular, clinical practice guidelines, fracture risk assessment, and evidence of treatment effectiveness in men are addressed.

Citing Articles

A relevant investigation of the degree of cement diffusion after robot-assisted percutaneous vertebroplasty.

Zhu Y, Chen H, Li L, Yang Y, Jia Y, Liu C BMC Musculoskelet Disord. 2025; 26(1):77.

PMID: 39844119 PMC: 11753145. DOI: 10.1186/s12891-025-08315-6.

Combining untargeted and targeted metabolomic profiling reveals principal differences between osteopenia, Osteoporosis and healthy controls.

Tan B, Cheng Y, Li J, Zheng Y, Xiao C, Guo H Aging Clin Exp Res. 2025; 37(1):28.

PMID: 39833609 PMC: 11746959. DOI: 10.1007/s40520-024-02923-3.

Alendronate for Effective Treatment of Male Osteoporosis: An Insight.

Al Lawati H, Al Busaidi S, Al Rawahi T, Al Lawati A, Kifah A, Das S Curr Pharm Des. 2024; 31(1):26-36.

PMID: 39238374 DOI: 10.2174/0113816128310838240820065324.

Clinical characteristics and risk factors of osteoporosis among older Asian men with type-2 diabetes mellitus, hypertension, or hyperlipidaemia.

Tan Y, Ng D, Gunasekaran K, Lim W, Tan N Arch Osteoporos. 2024; 19(1):83.

PMID: 39235564 PMC: 11377474. DOI: 10.1007/s11657-024-01442-y.

Risk factors for nonunion of osteoporotic vertebral compression fracture: a case‒control study.

Liao S, Xu Y, Liu J, Jiang L, Dai G, Wang Y BMC Musculoskelet Disord. 2024; 25(1):295.

PMID: 38627756 PMC: 11020417. DOI: 10.1186/s12891-024-07386-1.

References

Gielen E, Vanderschueren D, Callewaert F, Boonen S . Osteoporosis in men. Best Pract Res Clin Endocrinol Metab. 2011; 25(2):321-35. DOI: 10.1016/j.beem.2010.08.012. View

Kanis J, Johansson H, Oden A, Cooper C, McCloskey E . Worldwide uptake of FRAX. Arch Osteoporos. 2014; 9:166. DOI: 10.1007/s11657-013-0166-8. View

Kanis J, McCloskey E, Johansson H, Oden A, Melton 3rd L, Khaltaev N . A reference standard for the description of osteoporosis. Bone. 2008; 42(3):467-75. DOI: 10.1016/j.bone.2007.11.001. View

Duan Y, Beck T, Wang X, Seeman E . Structural and biomechanical basis of sexual dimorphism in femoral neck fragility has its origins in growth and aging. J Bone Miner Res. 2003; 18(10):1766-74. DOI: 10.1359/jbmr.2003.18.10.1766. View

Herrera A, Lobo-Escolar A, Mateo J, Gil J, Ibarz E, Gracia L . Male osteoporosis: A review. World J Orthop. 2013; 3(12):223-34. PMC: 3557324. DOI: 10.5312/wjo.v3.i12.223. View

Pike C, Birnbaum H, Schiller M, Sharma H, Burge R, Edgell E . Direct and indirect costs of non-vertebral fracture patients with osteoporosis in the US. Pharmacoeconomics. 2010; 28(5):395-409. DOI: 10.2165/11531040-000000000-00000. View

Silva D, Coelho A, Dumke A, Valentini J, de Nunes J, Stefani C . Osteoporosis prevalence and associated factors in patients with COPD: a cross-sectional study. Respir Care. 2011; 56(7):961-8. DOI: 10.4187/respcare.01056. View

Bischoff-Ferrari H, Willett W, Wong J, Giovannucci E, Dietrich T, Dawson-Hughes B . Fracture prevention with vitamin D supplementation: a meta-analysis of randomized controlled trials. JAMA. 2005; 293(18):2257-64. DOI: 10.1001/jama.293.18.2257. View

Kaufman J, Orwoll E, Goemaere S, San Martin J, Hossain A, Dalsky G . Teriparatide effects on vertebral fractures and bone mineral density in men with osteoporosis: treatment and discontinuation of therapy. Osteoporos Int. 2004; 16(5):510-6. DOI: 10.1007/s00198-004-1713-3. View

10.

Drake M, Murad M, Mauck K, Lane M, Undavalli C, Elraiyah T . Clinical review. Risk factors for low bone mass-related fractures in men: a systematic review and meta-analysis. J Clin Endocrinol Metab. 2012; 97(6):1861-70. DOI: 10.1210/jc.2011-3058. View

11.

Johnell O, Kanis J . An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. Osteoporos Int. 2006; 17(12):1726-33. DOI: 10.1007/s00198-006-0172-4. View

12.

De Oliveira D, Fighera T, Bianchet L, Kulak C, Kulak J . Androgens and bone. Minerva Endocrinol. 2012; 37(4):305-14. View

13.

Schuit S, van der Klift M, Weel A, de Laet C, Burger H, Seeman E . Fracture incidence and association with bone mineral density in elderly men and women: the Rotterdam Study. Bone. 2004; 34(1):195-202. DOI: 10.1016/j.bone.2003.10.001. View

14.

Rousculp M, Long S, Wang S, Schoenfeld M, Meadows E . Economic burden of osteoporosis-related fractures in Medicaid. Value Health. 2007; 10(2):144-52. DOI: 10.1111/j.1524-4733.2006.00161.x. View

15.

Cosman F, de Beur S, LeBoff M, Lewiecki E, Tanner B, Randall S . Clinician's Guide to Prevention and Treatment of Osteoporosis. Osteoporos Int. 2014; 25(10):2359-81. PMC: 4176573. DOI: 10.1007/s00198-014-2794-2. View

16.

Cohen-Solal M, Baudoin C, Omouri M, Kuntz D, De Vernejoul M . Bone mass in middle-aged osteoporotic men and their relatives: familial effect. J Bone Miner Res. 1998; 13(12):1909-14. DOI: 10.1359/jbmr.1998.13.12.1909. View

17.

Maclean C, Newberry S, Maglione M, McMahon M, Ranganath V, Suttorp M . Systematic review: comparative effectiveness of treatments to prevent fractures in men and women with low bone density or osteoporosis. Ann Intern Med. 2007; 148(3):197-213. DOI: 10.7326/0003-4819-148-3-200802050-00198. View

18.

Kanis J, Bianchi G, Bilezikian J, Kaufman J, Khosla S, Orwoll E . Towards a diagnostic and therapeutic consensus in male osteoporosis. Osteoporos Int. 2011; 22(11):2789-98. PMC: 3555694. DOI: 10.1007/s00198-011-1632-z. View

19.

Malabanan A, Rosen H, Vokes T, Deal C, Alele J, Olenginski T . Indications of DXA in women younger than 65 yr and men younger than 70 yr: the 2013 Official Positions. J Clin Densitom. 2013; 16(4):467-71. DOI: 10.1016/j.jocd.2013.08.002. View

20.

Becker D, Kilgore M, Morrisey M . The societal burden of osteoporosis. Curr Rheumatol Rep. 2010; 12(3):186-91. DOI: 10.1007/s11926-010-0097-y. View